Diasorin SpA (CHIX:DIAM) Price-to-Tangible-Book: (As of Sep. 09, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:DIAM Diasorin SpA CHIX:DIAM
76 GF Score
Price €75.99
GF Value €88.94
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is Diasorin SpA Price-to-Tangible-Book?

As of today (2026-09-09), Diasorin SpA's share price is €75.99. Diasorin SpA's Tangible Book per Share of Jun. 2026 for the quarter that ended in Jun. 2026 was €-8.16. Hence, Diasorin SpA's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Diasorin SpA's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, Diasorin SpA's highest Price to Tangible Book Ratio was 20.12. The lowest was 9.50. And the median was 12.78.

CHIX:DIAm's Price-to-Tangible-Book is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 2.59
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Diasorin SpA's share price is €75.99. Diasorin SpA's Book Value per Sharefor the quarter that ended in Jun. 2026 was €28.76. Hence, Diasorin SpA's P/B Ratio of today is 2.64.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Diasorin SpA Price-to-Tangible-Book Related Terms


Diasorin SpA Price-to-Tangible-Book Historical Data

* Premium members only.

The historical data trend for Diasorin SpA's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diasorin SpA Price-to-Tangible-Book Chart

Diasorin SpA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Diasorin SpA Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CHIX:DIAM vs TMO, DHR, NTRA: Price-to-Tangible-Book Comparison

For the Diagnostics & Research subindustry, Diasorin SpA's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diasorin SpA Price-to-Tangible-Book vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Diasorin SpA's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Diasorin SpA's Price-to-Tangible-Book falls into.


CHIX:DIAM
76GF Score
Diasorin SpA CHIX:DIAM
Price-to-Tangible-Book is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Diasorin SpA Price-to-Tangible-Book Calculation

Diasorin SpA's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Jun. 2026 )
=75.99/-8.162
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Is Diasorin SpA (CHIX:DIAM) Overvalued in 2026?

Based on GuruFocus' analysis, Diasorin SpA stock appears to be undervalued. The current stock price of €75.99 is trading 14.6% below its estimated GF Value™ of €88.94. GuruFocus considers Diasorin SpA to be Modestly Undervalued.

Key valuation signals for CHIX:DIAM:

  • Price-to-Tangible-Book:
  • GF Value™: €88.94 vs. price of €75.99 (14.6% below fair value)
  • GF Score™: 76/100 with 8 warning signs

No single metric tells the full story. See the CHIX:DIAM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Diasorin SpA Business Description

Address Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040
Diasorin develops and manufactures a broad portfolio of in vitro diagnostics for detecting pathogens and sample contamination from the human body, as well as for use in industrial settings, such as food and water contamination testing. The company operates three segments: immunodiagnostics (69% of sales), molecular diagnostics (16%), and licensed technologies (14%). Diasorin was an important manufacturer of covid tests, which boosted its profits during the pandemic, but this segment's importance has decreased over the years, and in 2025, it accounted for only 1% of total sales.
76GF Score

Get the complete analysis for CHIX:DIAM

Price-to-Tangible-Book is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€75.99
Price
€88.94
GF Value